These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32726467)

  • 1. Oral mucositis in a SARS-CoV-2-infected patient: Secondary or truly associated condition?
    Tomo S; Miyahara GI; Simonato LE
    Oral Dis; 2022 Apr; 28 Suppl 1():963-967. PubMed ID: 32726467
    [No Abstract]   [Full Text] [Related]  

  • 2. The manifestation of oral mucositis in COVID-19 patients: A case-series.
    Riad A; Kassem I; Badrah M; Klugar M
    Dermatol Ther; 2020 Nov; 33(6):e14479. PubMed ID: 33125803
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy.
    Faria KM; Gomes-Silva W; Kauark-Fontes E; Bonfim-Alves CG; Kowalski LP; Prado-Ribeiro AC; Vechiato-Filho AJ; Lopes MA; Marta GN; de Castro G; Leme AFP; Migliorati CA; Santos-Silva AR; Brandão TB
    Support Care Cancer; 2020 Oct; 28(10):4545-4548. PubMed ID: 32696245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report.
    Corchuelo J; Ulloa FC
    Int J Infect Dis; 2020 Nov; 100():154-157. PubMed ID: 32882435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice.
    Bonomo P; Elad S; Kataoka T; Bossi P;
    Support Care Cancer; 2021 May; 29(5):2255-2258. PubMed ID: 33392774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.
    Hüpsch-Marzec H; Dziedzic A; Skaba D; Tanasiewicz M
    Med Pr; 2021 Dec; 72(6):685-692. PubMed ID: 34596170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection.
    Surboyo MD; Ernawati DS; Budi HS
    Minerva Dent Oral Sci; 2021 Aug; 70(4):161-168. PubMed ID: 34269548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SARS-CoV-2 infection on human reproduction.
    Yang M; Wang J; Chen Y; Kong S; Qiao J
    J Mol Cell Biol; 2021 Dec; 13(10):695-704. PubMed ID: 34003284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 impact on oral health: A general view.
    Parra-Ortega I; Rodriguez-Ortega D
    Bol Med Hosp Infant Mex; 2021 Jan; 78(2):91-94. PubMed ID: 33497372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection.
    Szarpak L; Filipiak KJ; Gasecka A; Pruc M; Drozd A; Jaguszewski MJ
    Med Hypotheses; 2021 Jan; 146():110454. PubMed ID: 33338954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Damage May Mimic Retinitis and Optic Neuritis in COVID-19.
    Finsterer J; Scorza FA; Scorza CA; Fiorini AC
    Curr Eye Res; 2021 Dec; 46(12):1934-1935. PubMed ID: 33661715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 manifestation in the oral cavity - a narrative literature review.
    Kusiak A; Cichońska D; Tubaja M; Skorek A; Jereczek-Fossa BA; Corrao G; Marvaso G; Alterio D
    Acta Otorhinolaryngol Ital; 2021 Oct; 41(5):395-400. PubMed ID: 34734574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive infectious mucocutaneous eruption in children diagnosed with COVID-19.
    Bowe S; O'Connor C; Gleeson C; Murphy M
    Pediatr Dermatol; 2021 Sep; 38(5):1385-1386. PubMed ID: 34542915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic neuritis following SARS-CoV-2 infection.
    Rodríguez-Rodríguez MS; Romero-Castro RM; Alvarado-de la Barrera C; González-Cannata MG; García-Morales AK; Ávila-Ríos S
    J Neurovirol; 2021 Apr; 27(2):359-363. PubMed ID: 33755923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on SARS-CoV-2 infection in children.
    Martins MM; Prata-Barbosa A; da Cunha AJLA
    Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature.
    Nieto-Benito LM; Hernández de la Torre-Ruiz E; Balaguer-Franch I; Rosell-Díaz ÁM; Mateos-Mayo A; Herrero-Sanchez A; Lacasta-Plasín C; García-Piqueras P; Barchino-Ortiz L; Bergón-Sendín M; Pulido-Pérez A; Baniandrés-Rodríguez O; Rodriguez-Lomba E; Molina-Lopez I; Suárez-Fernandez R
    Australas J Dermatol; 2021 Feb; 62(1):e98-e101. PubMed ID: 32920868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions.
    Altaie AM; Hamdy R; Venkatachalam T; Hamoudi R; Soliman SSM
    BMC Oral Health; 2021 Nov; 21(1):567. PubMed ID: 34749700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
    Ojelade M; Rodriguez A; Gonzalez D; Otokunrin D; Ramachandruni S; Cuevas E; Moon K; Tyler CG; Freeland M; Anderson M; Haire K; Orozco Y; Scipio F; Springer Y; Prot E; Shuford JA
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):348-349. PubMed ID: 33705368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
    Chiricosta L; Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.